STSS (Sharps Technology) GF Score : 22/100 (As of Mar. 28, 2025)

View and export this data going back to 2022. Start your Free Trial

What is Sharps Technology GF Score?

Sharps Technology has the GF Score of 22, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 8/10
2. Profitability Rank : 1/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 0/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Sharps Technology might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Sharps Technology's GF Score

For the Medical Instruments & Supplies subindustry, Sharps Technology's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sharps Technology's GF Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sharps Technology's GF Score distribution charts can be found below:

* The bar in red indicates where Sharps Technology's GF Score falls into.

Save Embed

;

Save Embed

;

Sharps Technology (NAS:STSS) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score	Performance Potential and All-in-One Screener Examples ⁽¹⁾
91 - 100	Highest outperformance potential
81 - 90	Good outperformance potential
71 - 80	Likely to have average performance
51 - 70	Poor future performance potential
0 - 50	Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Sharps Technology GF Score Related Terms

Thank you for viewing the detailed overview of Sharps Technology's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Sharps Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sharps Technology Inc (NAS:STSS) » Definitions » GF Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

105 Maxess Road, Suite 124, Melville, NY, USA, 11747

Website

https://www.sharpstechnology.com

Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes are designed to eliminate potentially infectious and accidental needlestick injuries.

Executives

Robert Michael Hayes	director, officer: Chief Executive Officer	75 BROOKSHIRE DRIVE, YOUNGSVILLE NC 27596
Andrew R. Crescenzo	officer: Chief Financial Officer	C/O ENZO BIOCHEM, 527 MADISON AVENUE, NEW YORK NY 10022
Timothy James Ruemler	director	3311 RIVERPARK CT., BENITA SPRINGS FL 34134
Alan R. Blackman	director, officer: CIO and COO	11502 ROBLES DR. REPP PLACE, TEMPLE TERRACE FL 33617
Paul K Danner	director
Soren Bo Christiansen	director	4059 SPRING VALLEY ROAD, DOYLESTOWN PA 18902
Brenda Baird Simpson	director	7336 PRAIRIE STAR COURT,, PARKER CO 80134
Jason L. Monroe	director	14527 LINDALE ROSE LANE, HUMBLE TX 77379
Barry Boris Berler	officer: CTO and Inventor	77 HERZL STREET, RAMAT GAN L3 5244352